ClinicalTrials.Veeva

Menu

Trans-aortic Valve Replacement and Renal Infarction

S

Sheba Medical Center

Status

Unknown

Conditions

Renal Infarction

Treatments

Diagnostic Test: Magnetic Resonance test for kidney

Study type

Observational

Funder types

Other

Identifiers

NCT03474250
4887-18

Details and patient eligibility

About

Kidney Magnetic Resonance assessment before and after undergoing transcatheter aortic valve replacement

Full description

Each patient will undergo Magnetic Resonance assessment of the kidneys before the TAVR. on the third to 7th day after the ATVR, a second MRI to the kidneys will be performed. we will assess the changes and new lesions between both MRI tests and will perform a qualitative and quantitative measurement.

Enrollment

20 estimated patients

Sex

All

Ages

18 to 99 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Severe symptomatic aortic stenosis
  • Patient is able to lay down supine for 20 min (the time needed to perform the MRI) without any difficulties.

Exclusion criteria

  • Patient is on chronic renal replacement therapy (Dialysis)
  • Documented Thrombus in the left ventricle or left atria

Trial contacts and locations

1

Loading...

Central trial contact

Arwa Younis, Doctor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems